Recursion Pharmaceuticals, Inc. announced in February 2024, the company named Kristen Rushton, M.B.A. as Chief Business Operations Officer. Ms. Rushton has worked at the company for over 6 years, previously serving as Senior Vice President of Business Operations. Prior to the company, Ms. Rushton worked at Myriad Genetics and Myrexis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | +3.57% | +10.48% | -17.65% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.65% | 1.93B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals, Inc. Appoints Kristen Rushton as Chief Business Operations Officer